Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Nitazoxanide shows promise for COVID-19 treatment in animal model

In a recent study posted to the bioRxiv* pre-print server, researchers demonstrated that Nitazoxanide (NTZ), an oral drug, broadly inhibits replication of several severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs) in preclinical models of infection.

13 Feb 2022

Wearable sensors for COVID-19 mitigation

In a recent study posted to the medRxiv* pre-print server, researchers simulated several wearable sensor deployment scenarios to demonstrate the potential of digital contact tracing technology in mitigating the coronavirus disease 2019 (COVID-19) pandemic.

13 Feb 2022

Study shows IgA antibodies play a significant role in neutralizing SARS-CoV-2

A recent paper by researchers from Australia, currently available on the medRxiv* preprint server, shows how Immunoglobulin A (IgA) antibodies in individuals who were infected with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) contribute to the neutralization of the virus and its variants, even though this response is heterogeneous and less potent when compared to IgG antibodies.

13 Feb 2022

Assessing potential allergic reactions in COVID-19 vaccinated patients

Researchers analyze suspected reactions in patients vaccinated with the first and/or second dose of SARS-CoV-2 vaccines.

13 Feb 2022

Real world evidence on acquired immunity from vaccines and SARS-CoV-2 infection

Researchers assess the incidence of SARS-CoV-2 breakthrough cases and reinfections among unvaccinated and vaccinated individuals.

13 Feb 2022

Study examines the viral dynamics of Hong Kong's four SARS-CoV-2 waves

Researchers evaluate the efficiency of COVID-19 elimination strategies implemented in Hong Kong.

13 Feb 2022

Researchers find unprecedented rise in HIV incidence rate among people who inject drugs in Tijuana

At the February 11, 2022 opening of the Conference on Retroviruses and Opportunistic Infection, researchers at University of California San Diego School of Medicine presented data that suggests a new HIV outbreak in Tijuana, Mexico, driven in part by "drug tourism" unabated by the closure of the international border due to the COVID-19 pandemic.

12 Feb 2022

Cancer patients undergoing active treatment may be more vulnerable to COVID-19-related misinformation

Cancer patients undergoing active treatment were more likely to believe misinformation related to COVID-19 than those without a history of cancer, according to a new study led by researchers at Virginia Commonwealth University.

12 Feb 2022

New government fund will provide holidays for more than 800 families facing difficult times

Families struggling financially, or facing illness, isolation or bereavement, will have an opportunity for a weekend break thanks to a new government fund.

11 Feb 2022

Identifying and targeting ‘fence-sitters’ early in pandemic could help reduce vaccine hesitancy

Identifying adults who are ambivalent about vaccines early in a pandemic and finding community leaders who can help spread reliable information within their communities could help reduce vaccine hesitancy, according to a new University of Michigan study.

11 Feb 2022

New insights into the effects of COVID-19 vaccination on dialysis patients

Two studies in CJASN offer a better understanding of the effects of COVID-19 vaccination on individuals with kidney failure who are undergoing long-term dialysis.

11 Feb 2022

COPD patients more compliant with COVID-19 restrictions in the UK

A new study reports on the tendency among COPD patients in the UK to practice social distancing, compared to the public at large, during the COVID-19 pandemic.

11 Feb 2022

Model shows booster doses and antiviral pills may enable relaxation of SARS-CoV-2 social distancing

Researchers suggest that social distancing could be relaxed in order to reduce the number of severe cases of COVID-19, rather than stop the transmission of the SARS-CoV-2.

11 Feb 2022

SARS-CoV-2 nucleocapsid G215C variation may explain Delta severity

A new study shows that the SARS-CoV-2 nucleocapsid protein has unique properties that allow the virus to become more infective in the presence of certain mutations.

11 Feb 2022

What are taxpayers spending for those ‘free’ covid tests? The government won’t say.

The four free covid-19 rapid tests President Joe Biden promised in December for every American household have begun arriving in earnest in mailboxes and on doorsteps.

11 Feb 2022

Showcasing STEM Women in Medical Science

Every year, the UN celebrates the International Day of Women and Girls in Science. For 2022, the focus is placed on recognizing the role women and girls play in STEM as beneficiaries and as agents of change.

11 Feb 2022

Exits by Black and Hispanic teachers pose a new threat to covid-era education

Lynette Henley needed one more year to receive her full pension after 40 years as a teacher, but she couldn't convince herself it was worth the risk.

11 Feb 2022

Study investigates population immunity to SARS-CoV-2 through heterogenous pathways

A new study demonstrates COVID-19 vaccine-specific differences in the antibody responses and memory B-cell immunity in a sample population comprising of 197 vaccinated individuals in Mexico.

11 Feb 2022

Survey demonstrates financial and mental health damage that may outlive the COVID threat

New Yorkers entering their third year of COVID have bleak views of the near-term economy and a strong conviction that vaccines should be required for those seeking to participate in their city's indoor activities (69%), to work in its service industries (66%) or schools (69%), and even to travel on airplanes (68%).

11 Feb 2022

Novel molecule shows ability to inhibit the replication of all coronaviruses

Uppsala researchers have succeeded in designing a molecule that inhibits the replication of coronaviruses and that has great potential for development into a drug suitable for treating COVID-19.

10 Feb 2022

Pandemic News and Research

Further Reading

Nitazoxanide shows promise for COVID-19 treatment in animal model

Wearable sensors for COVID-19 mitigation

Study shows IgA antibodies play a significant role in neutralizing SARS-CoV-2

Assessing potential allergic reactions in COVID-19 vaccinated patients

Real world evidence on acquired immunity from vaccines and SARS-CoV-2 infection

Study examines the viral dynamics of Hong Kong's four SARS-CoV-2 waves

Researchers find unprecedented rise in HIV incidence rate among people who inject drugs in Tijuana

Cancer patients undergoing active treatment may be more vulnerable to COVID-19-related misinformation

New government fund will provide holidays for more than 800 families facing difficult times

Identifying and targeting ‘fence-sitters’ early in pandemic could help reduce vaccine hesitancy

New insights into the effects of COVID-19 vaccination on dialysis patients

COPD patients more compliant with COVID-19 restrictions in the UK

Model shows booster doses and antiviral pills may enable relaxation of SARS-CoV-2 social distancing

SARS-CoV-2 nucleocapsid G215C variation may explain Delta severity

What are taxpayers spending for those ‘free’ covid tests? The government won’t say.

Showcasing STEM Women in Medical Science

Exits by Black and Hispanic teachers pose a new threat to covid-era education

Study investigates population immunity to SARS-CoV-2 through heterogenous pathways

Survey demonstrates financial and mental health damage that may outlive the COVID threat

Novel molecule shows ability to inhibit the replication of all coronaviruses

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News